Leonkare Pharmaceuticals Private Limited
About Leonkare Pharmaceuticals Private Limited
Data last updated:
Leonkare Pharmaceuticals Private Limited is a private limited company based in Kamrup, Assam, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 18 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U85300AS2019PTC019184. Its GSTIN is 18AADCL9058P1ZO (Assam).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ruma Mukharji and Dipankar Mukhopadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Bikram Sanyal Prabhat Complex Lokhra Main Road Near Bsnl Exchange, Kamrup, Assam, India – 781018.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.43 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹43,500 (net margin -30.4%) and EBITDA of -₹43,500 (EBITDA margin -30.4%). Revenue has declined at a compounded annual rate (CAGR) of 64% over three years and 39% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Bikram Sanyal Prabhat Complex Lokhra Main Road Near Bsnl Exchange, Kamrup, Assam, India – 781018
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Leonkare Pharmaceuticals Private Limited
The main business activity of Leonkare Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Leonkare Pharmaceuticals Private Limited FY 2025 filings available
Leonkare Pharmaceuticals Private Limited reported revenue of ₹1.43 Lakh (down 98% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Leonkare Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 39% over five years, including a 98% fall in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Leonkare Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹43,500 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹43,500 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Leonkare Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -30.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -30.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Leonkare Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Leonkare Pharmaceuticals Private Limited
Leonkare Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kveepreksh Pharmaceuticals Private Limited | ₹1.45 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Phalodi, Rajasthan, India |
| Medcryst Pharmaceuticals Private Limited | ₹1.45 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Mypross Pharmaceuticals Private Limited | ₹1.44 Lakh (FY 2023) | •••• | •••• | -68.0% | •••• | New Delhi, Delhi, India |
| Alan Pharmaceuticals Private Limited | ₹1.44 Lakh (FY 2021) | •••• | •••• | -80.0% | •••• | Silchar, Assam, India |
| Future Digital Dental Private Limited | ₹1.44 Lakh (FY 2019) | •••• | •••• | -45.0% | •••• | Hyderabad, Telangana, India |
| Leonkare Pharmaceuticals Private Limited this company | ₹1.43 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Kamrup, Assam, India |
| Aardix Pharmaceuticals (OPC) Private Limited | ₹1.43 Lakh (FY 2022) | •••• | •••• | -4.0% | •••• | Kolkata, West Bengal, India |
| Silica Consona Private Limited | ₹1.42 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Best Care Pharmaceuticals Private Limited | ₹1.41 Lakh (FY 2024) | •••• | •••• | -27.0% | •••• | Haridwar, Uttarakhand, India |
| Doctsmedi Pharmaceuticals Private Limited | ₹1.41 Lakh (FY 2024) | •••• | •••• | -69.0% | •••• | Lucknow, Uttar Pradesh, India |
| Novencia Pharmaceuticals Private Limited | ₹1.4 Lakh (FY 2024) | •••• | •••• | •••• | Dehradun, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Leonkare Pharmaceuticals by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Leonkare Pharmaceuticals Private Limited
Leonkare Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruma Mukharji | Director | 18 Apr 2019 | 7 Years 5 Months | Current |
| Dipankar Mukhopadhyay | Director | 18 Apr 2019 | 7 Years 5 Months | Current |
Ownership and Shareholding of Leonkare Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Leonkare Pharmaceuticals Private Limited
Leonkare Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Leonkare Pharmaceuticals Private Limited
Leonkare Pharmaceuticals Private Limited has a workforce of 1 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Leonkare Pharmaceuticals Private Limited
Leonkare Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Dipankar Mukhopadhyay was appointed as Director on 18 Apr 2019.
Credit Ratings, Litigation & Regulatory Alerts for Leonkare Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Leonkare Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Leonkare Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Leonkare Pharmaceuticals Private Limited
Leonkare Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AADCL9058P1ZO | Assam | Active | 01 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Leonkare Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leonkare Pharmaceuticals Private Limited
Leonkare Pharmaceuticals is an active private limited company based in Kamrup, Assam, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 18 April 2019 (7+ years old) and is registered under CIN U85300AS2019PTC019184.
Leonkare Pharmaceuticals reported revenue of ₹1.43 Lakh for FY 2025 (down 98% YoY).
Leonkare Pharmaceuticals has 2 current directors:
- Ruma Mukharji - Director
- Dipankar Mukhopadhyay - Director
Leonkare Pharmaceuticals reported a net loss of ₹43,500 (net margin -30.4%) and EBITDA of -₹43,500 (EBITDA margin -30.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Leonkare Pharmaceuticals is -64% over three years and -39% over five years. In the latest year (FY 2025) revenue fell 98%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Leonkare Pharmaceuticals is 18AADCL9058P1ZO, registered in Assam.
The CIN (Corporate Identification Number) of Leonkare Pharmaceuticals is U85300AS2019PTC019184. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leonkare Pharmaceuticals was incorporated on 18 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Leonkare Pharmaceuticals by revenue are Kveepreksh Pharmaceuticals Private Limited, Medcryst Pharmaceuticals Private Limited, Mypross Pharmaceuticals Private Limited, Alan Pharmaceuticals Private Limited, Future Digital Dental Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals).
Dipankar Mukhopadhyay was appointed as Director on 18 Apr 2019. Ruma Mukharji was appointed as Director on 18 Apr 2019.
The registered office of Leonkare Pharmaceuticals is at CO Bikram Sanyal Prabhat Complex Lokhra Main Road Near Bsnl Exchange, Kamrup, Assam, India – 781018.